PDL BIOPHARMA INC - NOTE 4.000% 2/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2018

Type / Class
Debt / NOTE 4.000% 2/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of PDL BIOPHARMA INC - NOTE 4.000% 2/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2018 Q1 $0 $0 -$118,561,560 0
2017 Q4 $118,816,000 $118,561,560 +$1,246,153 100.0% 16
2017 Q3 $117,529,013 $117,344,476 +$2,689,299 100.0% 18
2017 Q2 $114,865,000 $114,408,388 -$668,996 100.0% 19
2017 Q1 $115,682,000 $114,499,851 +$1,922,650 99.04% 17
2016 Q4 $113,836,013 $111,037,013 -$97,347,183 97.46% 20
2016 Q3 $198,571,465 $208,034,013 -$2,984,215,131 97.14% 29
2016 Q2 $212,916,019 $201,745,018 -$10,003,705 94.75% 29
2016 Q1 $224,682,000 $189,395,000 -$2,689,389 90.31% 30
2015 Q4 $215,412,000 $171,672,000 -$22,663,994 80.06% 27
2015 Q3 $264,043,019 $231,639,017 -$16,302,067 88.1% 39
2015 Q2 $272,240,014 $258,220,013 +$4,165,934 94.81% 42
2015 Q1 $260,852,606 $249,723,972 -$20,439,939 95.69% 34
2014 Q4 $258,042,517 $248,212,246 -$42,800,208 95.97% 37
2014 Q3 $302,423,000 $294,846,000 +$7,644,790 97.43% 36
2014 Q2 $281,342,503 $317,022,828 +$2,315,841 114.45% 39
2014 Q1 $286,734,934 $302,235,529 +$283,279,529 105.25% 31